MC Healthcare Ventures — 2012 Investments
1 investments dated 2012 · listed companies and verified rows first · show all
FerroKin BiosciencesinFeb 2012acquired by Shire
Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
BiotechSan Carlos, US
Hugh Y. Rienhoff, Jr., M.D.(Executive Officer, Director)
BoardMarten Steen(Director)Dennis Henner, Ph.D.(Director)Bryant E. Fong(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.